Nina is 39, a project manager, and the kind of woman who researches everything thoroughly before committing to anything. She had read about Mounjaro for months before starting. She understood the mechanism. She knew weight loss was possible.
Last reviewed by the Carisma Medical Team — 2026
Nina is 39, a project manager, and the kind of woman who researches everything thoroughly before committing to anything. She had read about Mounjaro for months before starting. She understood the mechanism. She knew weight loss was possible. What she hadn't fully prepared for was day four of her first week — lying on the sofa at 7pm, nausea rolling through her in quiet waves, wondering whether this was normal or whether something had gone wrong.
She almost called to cancel her programme. She almost convinced herself this was another thing that wasn't going to work for her.
Understanding Mounjaro side effects in Malta — what is expected, what is manageable, and what requires attention — is exactly what this guide covers. What stopped Nina was the phone call she got on day seven — routine monitoring, built into her medically supervised programme. Her doctor confirmed that what she was experiencing was exactly what was expected, that it was temporary, and that most patients find it significantly easier after the first dose adjustment. She stayed. By week six, the nausea had faded. By week twelve, she was climbing the stairs at the office without thinking about it, noticing her clothes fitting differently, sleeping more soundly than she had in years.
Side effects are real. They deserve honest discussion — not minimised, not dramatised.
This article covers everything you need to know about Mounjaro side effects in Malta: what the clinical evidence says, what patients here actually experience, which effects resolve on their own, which ones require monitoring, and how a properly structured medically supervised programme makes a significant difference to how manageable all of it feels.
Key Takeaways - Mounjaro side effects are mostly gastrointestinal and strongest in the first 4–8 weeks - Nausea affects ~40–45% of patients but rarely leads to stopping treatment - Hair thinning is temporary and reversible — protein intake helps minimise it - Serious risks like pancreatitis are rare and screened for in supervised programmes - Clinically supervised care in Malta means you are never managing side effects alone - Results may vary — your clinical team adjusts your dose to match your individual response
Why Side Effects Happen with Mounjaro
How tirzepatide interacts with the digestive system
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist — meaning it activates two separate hormonal pathways simultaneously. One of those pathways, the GLP-1 mechanism, directly affects the digestive system in ways that are central to how the medication works.
GLP-1 receptors exist throughout the gut. When tirzepatide activates them, it slows gastric emptying — the rate at which food moves from your stomach into the small intestine. This is intentional and beneficial: it prolongs the feeling of fullness after meals, reduces the appetite signals your brain receives, and contributes meaningfully to caloric reduction over time. The glucagon-like peptide pathway is also key to how the medication improves insulin resistance and regulates metabolic rate over time.
The catch is that your digestive system is not immediately accustomed to this change. Food sitting longer in the stomach, motility patterns shifting, gut hormones adjusting — all of this can produce discomfort, particularly in the early weeks. The system is adapting to a new normal.
Most side effects from Mounjaro are gastrointestinal for this reason. They are a direct signal that the medication is doing what it is designed to do — and they are not a sign that something has gone wrong.
Why they are usually strongest at the start
The dose escalation schedule for Mounjaro begins at 2.5mg — a sub-therapeutic starting dose used specifically to allow the body to acclimatise. Every four weeks, the dose increases in 2.5mg increments toward the target therapeutic dose.
Each dose step can trigger a temporary renewal of milder side effects as the body adjusts upward. This is why many patients describe a pattern: discomfort in the first week or two of a new dose, which then settles before the next increase. Over time — typically by the third or fourth escalation step — the adaptation period becomes shorter and the symptoms less pronounced.
This is not a coincidence. It is the reason the titration schedule exists, and it is one of the most important reasons to follow that schedule carefully within a clinically supervised programme rather than self-managing dosing decisions.
The Most Common Side Effects
Nausea: when it peaks and how to ease it
Nausea is the most frequently reported side effect of Mounjaro. In the SURMOUNT-1 clinical trial — the largest tirzepatide trial in adults without type 2 diabetes, involving 2,539 participants over 72 weeks — nausea was reported by approximately 40 to 45 percent of participants at the highest dose (Jastreboff AM et al., NEJM 2022).
That number sounds alarming in isolation. In context, it matters enormously: most cases were mild to moderate, the majority resolved within the first four to eight weeks of each dose increase, and discontinuation due to nausea was uncommon when the medication was properly titrated.
In practice, nausea tends to be worst in the first few days after a dose injection. It is rarely constant — most patients describe it as coming in waves, often in the late afternoon or evening. Eating smaller, lower-fat meals, avoiding lying down immediately after eating, and timing injections strategically (many patients inject before bed so the peak side effect window occurs during sleep) can all help significantly.
If nausea is severe or persistent beyond two weeks, that is a conversation to have with your prescribing doctor — not something to push through alone.
Vomiting and diarrhoea
Vomiting was reported in approximately 25 percent of participants at the 15mg dose in SURMOUNT-1. Diarrhoea occurred in 17 to 23 percent across doses. Both are more common at higher doses and during the early escalation phase.
The practical reality is that most people who experience vomiting report it as occasional rather than frequent — one or two episodes clustered around the first days after injection, rather than a persistent daily experience. Diarrhoea similarly tends to be transient, resolving within a few weeks as the gut adapts.
If either symptom is frequent, prolonged, or severe enough to affect daily functioning, dose adjustment may be appropriate. A medically supervised programme allows this to happen quickly and safely, rather than leaving patients to manage uncertainty alone.
Constipation and bloating
Because Mounjaro slows gastric motility throughout the digestive tract, constipation is as common as diarrhoea — affecting approximately 20 to 24 percent of participants in clinical trials. Some people cycle between both.
Bloating accompanies this in many patients, particularly in the early weeks. The most effective countermeasures are consistent hydration (at least two litres of water daily), gradual increases in dietary fibre from vegetables and wholegrains, and gentle movement. Harsh laxatives are generally not recommended without medical guidance.
Constipation that becomes uncomfortable or prolonged warrants discussion with your doctor. It is very rarely a reason to stop treatment, but it should be actively managed rather than ignored.
Fatigue in the first few weeks
Fatigue affects roughly 13 percent of patients in clinical data, and it often goes hand-in-hand with the initial GI side effects. When nausea is reducing food intake, the body is simultaneously adjusting to a significant caloric reduction — fatigue is a predictable response.
For many women, particularly those managing demanding professional and personal lives, fatigue in the first two to three weeks can feel disheartening. It helps to understand that this phase is temporary, that it typically eases as GI symptoms settle, and that adequate protein intake (around 1.2 to 1.6 grams per kilogram of body weight per day) during this period helps the body preserve energy and lean muscle mass.
Results may vary for each individual — some patients experience minimal fatigue; others find it significant in the early weeks. Either is within the range of what is considered normal.
Less Common Side Effects to Know About
Acid reflux and heartburn
Gastric slowing can increase the likelihood of acid reflux and heartburn, particularly in patients who are already prone to these. Avoiding large meals, not eating within two to three hours of lying down, and limiting alcohol, caffeine, and acidic foods can reduce the likelihood. Patients who have existing gastro-oesophageal reflux disease (GORD) should discuss this proactively with their prescribing doctor before starting Mounjaro.
Injection site reactions
Mild reactions at the injection site — redness, slight swelling, or small firm nodules — occur in approximately 5 to 7 percent of patients. These are generally transient and resolve without intervention. Rotating injection sites (abdomen, thigh, upper arm) and allowing the pen to reach room temperature before injecting can reduce discomfort. Severe or worsening reactions at the site should be reviewed by a healthcare provider.
Hair thinning (telogen effluvium): what causes it and whether it reverses
Hair thinning is one of the side effects that most surprises patients — largely because it is not caused by the medication directly but by the rapid caloric restriction and physiological stress of significant weight loss. The condition is called telogen effluvium: a temporary phase in the hair growth cycle triggered by nutritional changes, physical or metabolic stress.
It typically begins two to four months after the period of most rapid weight loss and is usually diffuse thinning rather than patchy loss. The reassuring fact is that telogen effluvium is almost universally reversible. Hair regrowth typically resumes once the body has adapted to its new weight and nutritional intake stabilises.
Maintaining adequate protein intake during active weight loss — the 1.2 to 1.6g per kilogram guideline mentioned above — is one of the most evidence-supported ways to minimise the extent and duration of hair thinning. A medically supervised programme includes this nutritional guidance as standard, which makes a real difference.
Rare but Serious Side Effects
Pancreatitis: signs to watch for
Acute pancreatitis is listed as a potential risk with GLP-1 receptor agonists, though causality has not been definitively established in clinical trials. In the SURMOUNT-1 data, rates of pancreatitis were low. However, the risk is taken seriously enough that Mounjaro is contraindicated in patients with a history of pancreatitis.
Warning signs to take seriously: severe, persistent pain in the upper abdomen that may radiate to the back, nausea and vomiting that is different from the usual medication-related type, fever. If you experience these symptoms, stop taking the medication and seek urgent medical attention.
Gallbladder issues
Rapid weight loss of any kind — not specific to Mounjaro — increases the risk of gallstone formation. Cholelithiasis (gallstones) was observed in approximately 1.1 percent of tirzepatide participants versus 0.4 percent of placebo participants in SURMOUNT-1. Symptoms of gallbladder problems include sharp pain in the upper right abdomen, pain after fatty meals, nausea, and fever. These warrant prompt medical assessment.
When to call your doctor immediately
Seek urgent medical attention if you experience: severe abdominal pain, persistent vomiting preventing any fluid intake, signs of severe allergic reaction (facial swelling, difficulty breathing, rapid heartbeat), vision changes, or any symptom that feels qualitatively different from the expected early side effects described above.
None of these is common. But they are non-negotiable reasons to seek care without delay.
How a Medically Supervised Programme Reduces Risk
Gradual dose escalation
The titration schedule for Mounjaro — starting at 2.5mg and increasing every four weeks under medical oversight — is not a formality. It is the primary mechanism by which side effects are managed. Starting too high or escalating too quickly dramatically increases the intensity and duration of GI symptoms. A medically supervised programme means someone with clinical expertise is making these decisions with you, not you navigating a dose schedule alone.
At Carisma Slimming clinic in Malta, dose management is part of every consultation. If a patient is struggling at a particular dose level, the protocol allows for extended time at that dose before escalation — something that is not possible when medication is obtained without supervision.
Regular check-ins and monitoring
Scheduled monitoring is not just a safeguard — it is, as Nina discovered, what keeps patients on track through difficult early weeks. A routine check-in on day seven is the difference between a patient making an informed decision to continue and a patient quietly stopping because they felt alone with their symptoms.
Our medically supervised programme includes structured touchpoints, blood work review where clinically indicated, and access to the clinical team between appointments when concerns arise. This ongoing relationship is one of the most significant differentiators between a supervised programme and an unsupported one — and it is why serious adverse events are caught early rather than escalated.
To learn more about how our GLP-1 programme works at every stage, visit our GLP-1 Medical Weight Loss Programme page.
Practical Tips for Managing Side Effects Day-to-Day
Eating habits that reduce nausea
The single most effective dietary change for Mounjaro-related nausea is reducing meal size significantly. With gastric emptying slowed, large meals create an uncomfortable volume of food in the stomach that takes much longer to move through. Smaller, more frequent meals — four to five times across the day rather than three larger ones — tend to be far better tolerated.
Foods that tend to worsen nausea on Mounjaro: high-fat meals, very spicy food, greasy or fried food, and alcohol. Foods that tend to be better tolerated: plain wholegrains, lean protein sources, steamed vegetables, Greek yoghurt, eggs. The Mediterranean dietary pattern — already culturally relevant for many patients in Malta — aligns well with what the evidence supports for managing GI symptoms during tirzepatide treatment.
Eating slowly, chewing thoroughly, and staying upright for at least an hour after meals all make a meaningful difference for most patients.
Staying hydrated on Mounjaro
Hydration is non-negotiable, particularly when vomiting or diarrhoea is present. Dehydration can compound fatigue, worsen headaches, and in severe cases require medical intervention. Aim for at least two litres of water daily, supplemented with electrolyte-containing drinks if GI losses have been significant.
Cold or room-temperature fluids are generally better tolerated than hot drinks during periods of nausea. Sipping steadily throughout the day is easier on the stomach than drinking large amounts at once.
When Side Effects Mean You Should Stop
Most side effects of Mounjaro are manageable, temporary, and resolve without requiring discontinuation. But there are circumstances where stopping — permanently or temporarily — is the right medical decision.
Stopping should be considered if: you experience a serious adverse event (pancreatitis, severe allergic reaction, significant gallbladder symptoms); if nausea or vomiting is severe and persistent enough to prevent adequate nutrition and hydration despite dose reduction; if a complicating medical condition emerges during treatment; or if, after honest clinical review, the balance of benefit and burden does not favour continuation for your individual situation.
This is a medical decision made collaboratively with your doctor — not a failure, and not something to decide alone. Results may vary for each individual, and for a small proportion of patients, Mounjaro may not be the right tool. A medically supervised programme means that decision is made with full clinical context and without judgement, and that the conversation about what comes next begins immediately. If you'd like to understand what a full medically supervised approach looks like, our slimming guide walks through the complete process.
FAQs About Mounjaro Side Effects in Malta
How long do Mounjaro side effects last?
For most patients, the most significant gastrointestinal side effects — nausea, vomiting, diarrhoea — are most pronounced in the first four to eight weeks of each dose escalation step and then ease considerably. By the time patients reach their target maintenance dose and have been stable on it for several weeks, the majority report that their digestive system has adapted and day-to-day life feels much more normal. A small proportion of patients continue to experience mild nausea intermittently throughout treatment. This is manageable rather than debilitating for most people.
Is nausea from Mounjaro severe enough to stop treatment?
For the majority of patients, no. In the SURMOUNT-1 trial, while approximately 40 to 45 percent of patients at the highest dose reported nausea, the rate of discontinuation due to nausea was low — most patients were able to continue with appropriate dose management. That said, for a minority, nausea is severe enough to require dose reduction or, in rare cases, stopping. The key difference between managing through it and stopping unnecessarily is having a clinical team available to adjust your dose, assess your symptoms, and confirm what is within expected parameters. Alone, uncertainty is harder to hold.
Can Mounjaro cause serious long-term health problems?
Based on current clinical evidence from the SURMOUNT programme and post-marketing data, serious long-term health problems from Mounjaro are uncommon in the populations it is approved for. The most significant risks — pancreatitis, gallbladder disease — are rare and are screened for in a proper medically supervised programme. The EMA approved Mounjaro for chronic weight management in November 2023 based on an extensive safety and efficacy review. Longer-term cardiovascular outcome data continues to emerge. As with any medication, individual medical history matters significantly — which is why a thorough medical assessment before starting is essential, not optional.
Does hair loss from Mounjaro grow back?
Yes — in almost all cases, yes. The hair thinning associated with Mounjaro (and with rapid weight loss in general) is telogen effluvium: a temporary disruption in the hair growth cycle triggered by the physiological stress of significant caloric restriction. It typically appears two to four months after the period of greatest weight loss and resolves as the body stabilises. Hair regrowth usually becomes visible within three to six months of the thinning peak. Optimising protein intake during active weight loss — aiming for 1.2 to 1.6g per kilogram of body weight — is the most evidence-supported way to reduce the extent and duration. If thinning is significant, mention it to your clinical team; thyroid function and iron stores are worth checking.
What should I eat to reduce Mounjaro nausea?
Small, frequent meals are more effective than three larger ones, as gastric emptying is slowed on Mounjaro and volume in the stomach directly affects nausea. Foods that tend to be best tolerated: plain wholegrains (oats, rice, wholegrain bread), lean protein (eggs, Greek yoghurt, grilled chicken, fish), steamed or soft-cooked vegetables, and bland soups. Foods to minimise: high-fat meals, fried or greasy food, alcohol, very spicy dishes, and anything acidic in large quantities. Eating slowly, chewing well, and staying upright after meals also helps. Many patients find that their naturally Mediterranean dietary habits — light on heavy fried food, high in fish, vegetables and wholegrains — already provide a good starting framework.
Are Mounjaro side effects worse than Ozempic?
The side effect profiles of Mounjaro (tirzepatide) and Ozempic/Wegovy (semaglutide) are broadly similar — both primarily cause gastrointestinal effects including nausea, vomiting, diarrhoea, and constipation. In head-to-head comparison from the SURMOUNT-5 trial (published in NEJM, 2024), tirzepatide produced approximately 47 percent greater weight loss than semaglutide at 72 weeks, with a comparable tolerability profile. Neither medication is definitively "worse" for side effects — individual responses vary considerably. Some patients tolerate one better than the other. The appropriate choice depends on your medical history, your response to initial treatment, your cardiovascular risk profile, and clinical judgement from your prescribing doctor.
What are the warning signs that I should call my doctor while on Mounjaro?
Contact your doctor promptly if you experience: severe or persistent abdominal pain (particularly upper abdomen radiating to the back, which may suggest pancreatitis), vomiting that prevents you from keeping any fluids down, pain in the upper right abdomen after eating (possible gallbladder), signs of an allergic reaction (facial swelling, difficulty breathing, rapid heartbeat, rash), significant vision changes, or any symptom that feels qualitatively different from the expected early side effects. In a medically supervised programme, you will have a clinical contact number for exactly these situations — you should never feel that you are managing uncertainty alone between appointments.
Your Next Step in Malta
If you have been researching Mounjaro and side effects have been the thing giving you pause — that is a reasonable and sensible response. Wanting honest information before you start is not anxiety; it is exactly the right approach.
The truth is that side effects are real, they are manageable, and in a properly structured medically supervised programme, you are never navigating them alone. The patients who do best are the ones who have clinical support from day one — not because the medication is dangerous, but because having a doctor available on day seven makes the difference between staying the course and giving up before the treatment has had a chance to work.
You deserve support that is built around your life, your health history, and your individual response — not a one-size prescription sent without follow-up.
Book your free consultation at Carisma Slimming Malta and speak directly with our clinical team. We will answer every question you have — including the ones you haven't thought to ask yet.
Picture yourself at week twelve. The nausea has settled. Your clothes are fitting differently. You climbed the stairs this morning without thinking about it. You slept through the night. That is not a distant possibility — it is what medically supervised care, done properly, makes possible.
With you every step, Katya
Image Credits
Hero Image URL: https://images.pexels.com/photos/7579831/pexels-photo-7579831.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: cottonbro studio • Pexels Page: https://www.pexels.com/photo/a-doctor-talking-the-patient-7579831/ • Alt text: Female doctor having a warm consultation with a patient in a bright clinic — understanding Mounjaro side effects Malta with professional medical support • Caption: A Carisma clinician walks you through what to expect — no surprises, just honest guidance. • Filename: mounjaro-side-effects-malta-doctor-consultation.jpg • Query used: doctor patient consultation
Inline Image URL: https://images.pexels.com/photos/15319047/pexels-photo-15319047.jpeg?auto=compress&cs=tinysrgb&dpr=2&h=650&w=940 • Photographer: beyzahzah • Alt text: Female nutritionist in a clinic office holding broccoli surrounded by fresh fruits, promoting healthy eating alongside medical treatment • Query used: medical wellness consultation woman
More from the blog
